- Prescribing Information
- For US Patients
The clinical benefits of DARZALEX®
DARZALEX® may help you live longer without your multiple myeloma getting worse. Combination regimens with DARZALEX® has been proven effective in multiple clinical studies—even for those who have failed certain previous treatments.
See how DARZALEX® was studied
-
I am newly diagnosed and cannot receive a stem cell transplant that uses my own stem cells (autologous stem cell transplant)
Learn about the DARZALEX® + Revlimid® (lenalidomide) + dexamethasone clinical trial
Learn about the DARZALEX® + Velcade® (bortezomib) + melphalan + prednisone clinical trial -
I am newly diagnosed and can receive a stem cell transplant that uses my own stem cells
Learn about the DARZALEX® + Velcade® (bortezomib) + thalidomide + dexamethasone clinical trial
-
I have received at least one prior medicine to treat my multiple myeloma
Learn about the DARZALEX® + Revlimid® (lenalidomide) + dexamethasone clinical trial
Learn about the DARZALEX® + Velcade® (bortezomib) + dexamethasone clinical trial -
I have received at least two prior medicines to treat my multiple myeloma, including Revlimid® (lenalidomide) and a proteasome inhibitor
Learn about the DARZALEX® + Pomalyst® (pomalidomide) + dexamethasone clinical trial
- I have received at least three prior medicines to treat my multiple myeloma, including a proteasome inhibitor and an immunomodulatory agent, or a proteasome inhibitor and an immunomodulatory agent did not work for me